Does Verrica Pharmaceuticals Inc (VRCA) Have What it Takes to be in Your Portfolio Wednesday?

Verrica Pharmaceuticals Inc (VRCA) is near the top in its industry group according to InvestorsObserver. VRCA gets an overall rating of 60. That means it scores higher than 60 percent of stocks. Verrica Pharmaceuticals Inc gets a 79 rank in the Biotechnology industry. Biotechnology is number 53 out of 148 industries.

VRCA has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on VRCA!

See Full VRCA Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 60 means the stock is more attractive than 60 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Verrica Pharmaceuticals Inc Stock Today?

Verrica Pharmaceuticals Inc (VRCA) stock is lower by -7.29% while the S&P 500 has risen 0.56% as of 12:09 PM on Wednesday, Nov 22. VRCA has fallen -$0.27 from the previous closing price of $3.69 on volume of 46,132 shares. Over the past year the S&P 500 has gained 13.99% while VRCA has risen 22.14%. VRCA lost -$1.07 per share the over the last 12 months. Click Here to get the full Stock Report for Verrica Pharmaceuticals Inc stock.